SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-10-000175
Filing Date
2010-02-09
Accepted
2010-02-09 17:26:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO THE SCHEDULE 13G sc13ga307422nek_02012010.htm SC 13G/A 233833
2 JOINT FILING AGREEMENT ex991sc13ga307422nek_020110.htm EX-99.1 31240
  Complete submission text file 0000921895-10-000175.txt   267213
Mailing Address 201 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 201 INDUSTRIAL ROAD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Subject) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45385 | Film No.: 10585365
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice